| Azafaros B.V.. (5/13/25). "Press Release: Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders". Leiden. |
2025-05-13 |
| Haya Therapeutics SA. (5/8/25). "Press Release: Haya Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases". Lausanne & San Diego, CA. |
2025-05-08 |
| Recursion Pharmaceuticals, Inc.. (5/6/25). "Press Release: Recursion to Participate in Upcoming Investor Conferences". Salt Lake City, UT. |
2025-05-06 |
| Recursion Pharmaceuticals, Inc.. (5/5/25). "Press Release: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update". Salt Lake City, UT. |
2025-05-05 |
| Tozaro Ltd.. (5/1/25). "Press Release: Tozaro Appoints Dr. Jason Slingsby MBA as CEO to Lead Company Strategy in Cell and Gene Therapy Sector". Bedfordshire. |
2025-05-01 |
| Oryzon Genomics S.A.. (4/24/25). "Press Release: Oryzon Raises €30 Million in Capital Increase". Madrid & Cambridge, MA. |
2025-04-24 |
| Tessellate Bio B.V.. (4/23/25). "Press Release: Boehringer Ingelheim and Tessellate Bio Partner to Develop First-in-class Precision Treatments for People with Hard-to-treat Cancers". Ingelheim & Amsterdam. |
2025-04-23 |
| Alis Biosciences Ltd.. (4/18/25). "Press Release: Alis Biosciences Launches Fund to Free over USD$30 Billion of Capital Trapped in Listed Development-stage Life Sciences and Biotech Companies". London. |
2025-04-18 |
| ProBioGen AG. (4/17/25). "Press Release: GlymaxX-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy". Berlin. |
2025-04-17 |
| Glycomine, Inc.. (4/16/25). "Press Release: Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG". San Carlos, CA. |
2025-04-16 |
| Sonrai Analytics Ltd.. (4/16/25). "Press Release: Sonrai and Paige Partner to Bring Advanced Machine Learning Capabilities to Biopharma". Belfast. |
2025-04-16 |
| AATec Medical GmbH. (4/15/25). "Press Release: AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development". Munich. |
2025-04-15 |
| Meribel Pharma Solutions. (4/15/25). "Press Release: Meribel Pharma Solutions Launches with Big Ambitions to Elevate Pharma Services to New Heights". |
2025-04-15 |
| Chromatin Bioscience Ltd.. (4/14/25). "Press Release: Chromatin Bioscience Signs Collaboration Agreement with Astellas". Edinburgh. |
2025-04-14 |
| Immunic, Inc.. (4/10/25). "Press Release: Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments". New York, NY. |
2025-04-10 |
| Cepheid. (4/9/25). "Press Release: Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-based Solutions". Oxford & Sunnyvale, CA. |
2025-04-09 |
| Sphere Bio Ltd.. (4/9/25). "Press Release: APAC Distribution Network Expanded to Strengthen Presence in Region". Cambridge. |
2025-04-09 |
| Angelini Ventures S.p.A.. (4/7/25). "Press Release: Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director". Rome. |
2025-04-07 |
| Dotmatics Ltd.. (4/2/25). "Press Release: Dotmatics Signs Definitive Agreement to Be Acquired by Siemens Advancing a New Era of AI-Driven Innovation in Life Sciences". Boston, MA. |
2025-04-02 |
| Coulter Partners. (4/1/25). "Press Release: Coulter Partners Announces Promotion of Penny Sadler to Managing Partner". |
2025-04-01 |
| Cosmo Pharmaceuticals N.V.. (4/1/25). "Press Release: Cosmo Appoints Federico Sommariva as Chief Legal Counsel". Dublin. |
2025-04-01 |
| Nuage Therapeutics S.L.. (4/1/25). "Press Release: Nuage Therapeutics Appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair". Barcelona. |
2025-04-01 |
| Amboss SE. (3/25/25). "Press Release: Amboss Closes €240M Financing Round and Expands Its Position as the Leading Co-pilot for Physicians Worldwide". Berlin & New York, NY. |
2025-03-25 |
| AstraZeneca plc. (3/21/25). "Press Release: AstraZeneca to Invest $2.5 Billion in New Global Strategic R&D Centre, Biotech Agreements and Manufacturing in Beijing". |
2025-03-21 |
| British Business Bank plc. (3/21/25). "Press Release: British Business Bank Commits up to £30m to Thena Capital’s Inaugural UK MedTech Fund". |
2025-03-21 |
| Oxford BioTherapeutics Ltd.. (3/19/25). "Press Release: Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer". Oxford & San Jose, CA. |
2025-03-19 |
| Sofinnova Partners. (3/18/25). "Press Release: Sofinnova Partners Exceeds Target with €165M Biotech Acceleration Fund, Europe’s Largest, with Strong Pharma Support". Paris. |
2025-03-18 |
| Sofinnova Partners. (3/18/25). "Press Release: Forth Tx Launches with Backing from Sofinnova Partners to Revolutionize Fibrosis Treatments". Edinburgh & Cambridge. |
2025-03-18 |
| [iito] Business Intelligence. (3/18/25). "Press Release: [iito] Business Intelligence Announces Major Changes in Its Social Media Strategy". Bremen. |
2025-03-18 |
| Sofinnova Partners. (3/18/25). "Press Release: Sofinnova Partners and Gustave Roussy Launch First Biotech Company through Strategic Partnership". Paris. |
2025-03-18 |
| AstraZeneca plc. (3/17/25). "Press Release: AstraZeneca Enters License Agreement with Alteogen for Subcutaneous Formulations of Multiple Oncology Assets". |
2025-03-17 |
| EsoBiotec SA. (3/17/25). "Press Release: EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition". Mont-Saint-Guibert. |
2025-03-17 |
| Haya Therapeutics SA. (3/13/25). "Press Release: Haya Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer". Lausanne & San Diego, CA. |
2025-03-13 |
| Centogene N.V.. (3/12/25). "Press Release: Centogene Closes Strategic Transaction with Private Equity Group Charme Capital Partners". Cambridge, MA, Rostock & Berlin. |
2025-03-12 |
| Valo Therapeutics Oy. (3/10/25). "Press Release: Valo Therapeutics Announces EUR 19m of Investment Funding and Expanded Clinical Trials". Helsinki, Naples & Perth. |
2025-03-10 |
| T-Therapeutics Ltd.. (3/10/25). "Press Release: T-Therapeutics Appoints Theodora Harold as Chief Executive Officer, Reflecting Company’s Ambitious Growth Plans and Progression into Therapeutic Development". Cambridge. |
2025-03-10 |
| Jazz Pharmaceuticals plc. (3/5/25). "Press Release: Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio". Dublin & Durham, NC. |
2025-03-05 |
| Xund Solutions GmbH. (3/5/25). "Press Release: Xund Secures Pre-Series A. 6 Million Euros to Strengthen European Leadership in AI-powered Healthcare". |
2025-03-05 |
| Trimtech Therapeutics Ltd.. (3/5/25). "Press Release: Trimtech Therapeutics Raises $31M Seed Funding to Advance Targeted Protein Degradation Pipeline for Treatment of Neurodegenerative Diseases". Cambridge. |
2025-03-05 |
| Epoch Biodesign Ldt.. (3/5/25). "Press Release: Epoch Biodesign Raises $18.3M to Turn the Plastic Crisis Into a Circular Revolution". London. |
2025-03-05 |
| Sofinnova Partners. (3/4/25). "Press Release: Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation". Paris. |
2025-03-04 |
| Thermo Fisher Scientific Inc.. (2/25/25). "Press Release: Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business". Waltham, MA. |
2025-02-25 |
| Sphere Bio Ltd.. (2/25/25). "Press Release: Sphere Fluidics Rebrands to Sphere Bio". Cambridge. |
2025-02-25 |
| Nuclera Ltd.. (2/24/25). "Press Release: Nuclera Appoints Seth Benson as Chief Financial Officer". Cambridge. |
2025-02-24 |
| Chromatin Bioscience Ltd.. (2/20/25). "Press Release: Chromatin Bioscience Joins JLABS EMEA". Edinburgh. |
2025-02-20 |
| Anbio Biotechnology. (2/20/25). "Press Release: Anbio Biotechnology Announces Closing of Initial Public Offering". Frankfurt a. M.. |
2025-02-20 |
| FibroGen, Inc.. (2/20/25). "Press Release: FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million". San Francisco, CA. |
2025-02-20 |
| Boehringer Ingelheim. (2/20/25). "Press Release: Boehringer Ingelheim and Partners Start Clinical Development of a First-in-Class, Inhaled Gene Therapy for People with Cystic Fibrosis". Ingelheim. |
2025-02-20 |
| Nuclera Ltd.. (2/18/25). "Press Release: Nuclera Appoints William J. Kullback as Non-Executive Director". Cambridge. |
2025-02-18 |
| Isopmorphic Labs Ltd.. (2/18/25). "Press Release: Isomorphic Labs Announces Novartis Collaboration Expansion". London. |
2025-02-18 |
| Anbio Biotechnology. (2/18/25). "Press Release: Anbio Biotechnology Announces Pricing of Initial Public Offering". Frankfurt a. M.. |
2025-02-18 |
| Latent Labs Ltd.. (2/13/25). "Press Release: Latent Labs Secures $50M in Funding to Realize the Potential of AI-powered, Programmable Biology". London & San Francisco, CA. |
2025-02-13 |
| Qureight Ltd.. (2/5/25). "Press Release: Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis". |
2025-02-05 |
| High-Tech Gründerfonds Management GmbH. (2/4/25). "Press Release: Akribion Therapeutics Exits from Stealth with €8m Seed Financing to Pioneer RNA-guided, Programmable cell depletion". |
2025-02-04 |
| Coulter Partners. (2/4/25). "Press Release: Coulter Partners Places Chief Business Officer at Our Future Health". |
2025-02-04 |
| Isopmorphic Labs Ltd.. (3/31/25). "Press Release: Isomorphic Labs Announces $600 Million Funding to Further Develop Its Next-generation AI Drug Design Engine and Advance Therapeutic Programs into the Clinic". London. |
2025-01-31 |
| Rentschler Biopharma SE. (1/30/25). "Press Release: Rentschler Biopharma Announces Strategic Realignment of Its Global Business Operations". Laupheim. |
2025-01-30 |
| Quibim S.L.. (1/28/25). "Press Release: Quibim Announces $50 Million in Series A Financing, Led by Asabys and Buenavista, to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers". Valencia & New York, NY. |
2025-01-28 |
| Forbion Capital Partners. (1/27/25). "Press Release: Forbion BioEconomy Fund I Surpasses €150 Million Target, Raising €164.5 Million with Strong Institutional LP Support". Naarden. |
2025-01-27 |
| Coulter Partners. (1/23/25). "Press Release: Coulter Partners Secures CEO Placement for NeoPhore". |
2025-01-23 |
| Circio Holding ASA. (1/21/25). "Press Release: 4basebio Partners with Circio to Build and Test circVec Synthetic DNA Vectors for Genetic Medicine and Vaccines". Oslo. |
2025-01-21 |
| Cormica Ltd.. (1/20/25). "Press Release: Cormica Expands European Operations with Acquisition of Zwisler Laboratorium GmbH". |
2025-01-20 |
| Chromatin Bioscience Ltd.. (1/20/25). "Press Release (News): Chromatin Bioscience Signs a Research Collaboration with Johnson & Johnson". |
2025-01-20 |
| Chromatin Bioscience Ltd.. (1/17/25). "Press Release: Chromatin Bioscience’s Synthetic Promoter Supports EsoBiotec’s ESO-T01 CAR-T Therapy as It Enters the Clinic". Edinburgh. |
2025-01-17 |
| Owlstone Medical Ltd.. (1/15/25). "Press Release: Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round". Cambridge. |
2025-01-15 |
| Bioptimus SAS. (1/14/25). "Press Release: Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology". |
2025-01-14 |
| GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London. |
2025-01-13 |
| Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
| Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. |
2025-01-09 |
| Oribiotech Ltd.. (1/9/25). "Press Release: Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships". London. |
2025-01-09 |
| EsoBiotec SA. (1/8/24). "Press Release: EsoBiotec Doses First Patient in Investigator Initiated Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma". Mont-Saint-Guibert. |
2025-01-08 |
| Medix Biochemica Oy. (1/8/25). "Press Release: Medix Biochemica Welcomes Stefan Schorling to Its Leadership Team". |
2025-01-08 |
| Oribiotech Ltd.. (1/7/25). "Press Release: Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers". London. |
2025-01-07 |
| Qiagen N.V.. (1/7/25). "Press Release: Qiagen Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content". Redwood City, CA & Venlo. |
2025-01-07 |
| Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA. |
2024-12-19 |
| NeoPhore Ltd.. (12/16/24). "Press Release: NeoPhore Appoints Michael Shih as Chief Executive Officer". London. |
2024-12-16 |
| 2cureX AB. (12/16/24). "Press Release: 2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of Commercial Expansion of Breakthrough Precision Oncology Products". |
2024-12-16 |
| Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. |
2024-12-12 |
| EsoBiotec SA. (12/11/24). "Press Release: EsoBiotec Begins Clinical Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma". Mont-Saint-Guibert. |
2024-12-11 |
| BenevolentAI Ltd.. (12/11/24). "Press Release: BenevolentAI Unveils Major Strategic Overhaul with Return to Original Mission". London. |
2024-12-11 |
| Siemens Healthineers AG. (12/10/24). "Press Release: Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging". |
2024-12-10 |
| Selvita S.A.. (12/10/24). "Press Release: Selvita Strengthens Management Structure in Sales and Drug Development Segment". Kraków. |
2024-12-10 |
| Relation Therapeutics Ltd.. (12/10/24). "Press Release: Relation Announces Two Strategic Collaborations with GSK to Advance Therapeutics for Fibrotic Diseases and Osteoarthritis". London. |
2024-12-10 |
| Oribiotech Ltd.. (12/10/24). "Press Release: Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies". London & Bad Homburg. |
2024-12-10 |
| Dotmatics LLC. (12/10/24). "Press Release: Dotmatics and Databricks Partner to Advance Scientific Intelligence in Life Sciences". Boston, MA. |
2024-12-10 |
| Aqemia SAS. (12/10/24). "Press Release: Aqemia Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK". Paris & London. |
2024-12-10 |
| Newcells Biotech Ltd.. (12/5/24). "Press Release: Newcells Biotech Raises Additional Funding from Investors". Newcastle. |
2024-12-05 |
| ViveBiotech S.L.. (12/4/24). "Press Release: ViveBiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities". |
2024-12-04 |
| Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. |
2024-12-04 |
| Orbit Discovery Ltd.. (12/3/24). "Press Release: Orbit Discovery and Evergreen Theragnostics Expand Research Collaboration to Advance Targeted Therapeutics Development". Oxford & Springfield, NJ. |
2024-12-03 |
| Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
| Metrion Biosciences Ltd.. (11/25/24). "Press Release: Metrion Biosciences Appoints Lee Patterson as CEO". Cambridge. |
2024-11-25 |
| Enveda. (11/21/24). "Press Release: Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates". Boulder, CO. |
2024-11-21 |
| Glox Therapeutics Ltd.. (11/20/24). "Press Release: Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens". Glasgow. |
2024-11-20 |
| Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge. |
2024-11-20 |
| Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA. |
2024-11-20 |
| CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. |
2024-11-14 |
| Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| Tessellate Bio B.V.. (11/4/24). "Press Release: Tessellate Bio Announces Appointment of Lara Boyd as Chief Business Officer". Amsterdam & Stevenage. |
2024-11-04 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
